IMNM includes anti-signal recognition particle (SRP) antibody myopathy, anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) myopathy, and autoantibody-negative IMNM (Allenbach et al., 2018). This evidence concerns the gene UCN2 and myopathy.